Review raises concerns about women's libido drug flibanserin
There are new concerns about the safety of the only female libido drug approved by the FDA. Flibanserin, sold under the brand name Addyi, was approved last summer. Supporters called it a victory for women suffering from lower sexual desire, but a review in a medical journal questions the quality of the drug. Dr. Tara Narula joins “CBS This Morning” to discuss the findings.